Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model

Lipids in Health and Disease

Volumn 10, Issue , 2011, Pages

  Cavallini, Daniela Cu ^a   Suzuki, Juliana Y ^a   Abdalla, Dulcinéia Sp ^b   Vendramini, Regina C ^a   Pauly Silveira, Nadiége D ^a   Roselino, Mariana N ^a   Pinto, Roseli A ^a   Rossi, Elizeu A ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Enterococcus faecium CRL 183; fecal microbiota; lipid parameters; probiotics

Indexed keywords

CARBOHYDRATE; DAIDZEIN; DAIDZIN; FAT; GENISTEIN; GENISTIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; OXIDIZED LOW DENSITY LIPOPROTEIN ANTIBODY; PROBIOTIC AGENT; PROTEIN; CHOLESTEROL; LIPID; PLANT EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BIFIDOBACTERIUM; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLOSTRIDIUM; CONTROLLED STUDY; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; FECES MICROFLORA; HYPERCHOLESTEROLEMIA; LACTOBACILLUS HELVETICUS; LIPID BLOOD LEVEL; MALE; NONHUMAN; RABBIT; SOYBEAN; ANIMAL; AORTA; BACTERIAL LOAD; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; DRUG SCREENING; FECES; FERMENTATION; METAGENOME; MICROBIOLOGY; PATHOLOGY;

ANIMALIA; BIFIDOBACTERIUM; CLOSTRIDIUM; ENTEROBACTERIACEAE; ENTEROCOCCUS; ENTEROCOCCUS FAECIUM; LACTOBACILLUS; LACTOBACILLUS HELVETICUS; ORYCTOLAGUS CUNICULUS;

ANIMALS; AORTA; ATHEROSCLEROSIS; BACTERIAL LOAD; CHOLESTEROL; DRUG EVALUATION, PRECLINICAL; ENTEROCOCCUS FAECIUM; FECES; FERMENTATION; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; METAGENOME; PLANT EXTRACTS; PROBIOTICS; RABBITS; SOYBEANS;

EID: 79960880510     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-10-126     Document Type: Article

References (53)

1. Human metabolic phenotype diversity and its association with diet and blood pressure. Holmes E, Loo RL, Stamler J, Bictash M, Yap IK, Chan Q, Ebbels T, De Iorio M, Brown IJ, Veselkov KA, Daviglus ML, Kesteloot H, Ueshima H, Zhao L, Nicholson JK, Elliott P, Nature 2008 453 396 400 10.1038/nature06882 18425110 (Pubitemid 351693125)
2. Importance of microbial colonization of the gut in early life to the development of immunity. Kelly D, King T, Aminov R, Mutat Res 2007 622 58 69 17612575 (Pubitemid 47211174)
3. Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA). Goff DA, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Bruce M, Psaty BM, Circulation 2006 113 647 656 10.1161/CIRCULATIONAHA.105.552737 16461837
4. Diet-induced metabolic improvements in a hamster model of hypercholesterolemia are strongly linked to alterations of the gut microbiota. Martínez I, Wallace G, Zhang C, Legge R, Benson AK, Carr TP, Moriyama EN, Walter J, Appl Environm Microbiol 2009 75 4175 4184 10.1128/AEM.00380-09
5. The gut microbiota as an environmental factor that regulates fat storage. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JL, Proc Natl Acad Sci 2004 101 15718 15723 10.1073/pnas.0407076101 15505215 (Pubitemid 39473554)
6. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Backhed F, Manchester JK, Semenkovich CF, Gordon JL, Proc Natl Acad Sci 2007 104 979 984 10.1073/pnas.0605374104 17210919 (Pubitemid 46154722)
7. Development of a novel fermented soymilk product with potential probiotic properties. Rossi EA, Vendramini RC, Carlos IZ, Pei YC, Valdez GF, Eur Food Res Technol 1999 209 305 307 10.1007/s002170050499
8. Effects of a novel fermented soy product on the serum lipids of hypercholesterolemic rabbits. Rossi EA, Vendramini RC, Carlos IZ, Ueiji IS, Squinzari M, Silva SI, Valdez GF, Arq Bras Cardiol 2000 74 213 216 10.1590/S0066-782X2000000300003
9. Efeito de um novo produto fermentado de soja sobre lípides séricos de homens adultos normocolesterolêmicos. Rossi EA, Vendramini CR, Carlos IZ, Oliveira MG, Valdez GF, Arch Latinoam Nutr 2003 53 47 51 12942871 (Pubitemid 37158138)
10. Intake of isoflavone-supplemented soy yogurt fermented with Enterococcus faecium lowers serum total cholesterol and non-HDL cholesterol of hypercholesterolemic rats. Rossi EA, Cavallini DCU, Carlos IZ, Vendramini RC, Damaso AR, Valdez GF, Eur Food Res Technol 2008 228 275 282 10.1007/s00217-008- 0932-9
11. Effects of isoflavone-supplemented soy yogurt on lipid parameters and atherosclerosis development in hypercholesterolemic rabbits: a randomized double-blind study. Cavallini DCU, Abdalla DSP, Vendramini RC, Bedani R, Bomdespacho LQ, Pauly-Silveira ND, Valdez GF, Rossi EA, Lipids Health Dis 2009 8 40 10.1186/1476-511X-8-40 19814806
12. Enzymatic determination of total serum cholesterol. Allain CA, Poon LS, Chan CSG, Richmond W, Fu PC, Clin Chem 1974 20 470 475 4818200
13. Methods of enzymatic analysis. Bergmeyer HW, London: Academic Press 1974 1890 1893
14. Soy protein with or without isoflavones, soy germ and soy germ extract, and daidzein lessen plasma cholesterol levels in golden syrian hamsters. Song T, Lee S-O, Murphy PA, Hendrich S, Exp Biol Med 2006 228 1063 1068
15. Joint Distribution of Non-HDL and LDL Cholesterol and Coronary Heart Disease Risk Prediction Among Individuals With and Without Diabetes. Liu J, Sempos C, Donahue RP, Dorn J, Trevisan M, Grundy SM, Diabetes Care 2005 28 1916 1921 10.2337/diacare.28.8.1916 16043732 (Pubitemid 41060963)
16. Soy protein isolate reduces the oxidizability of LDL and the generation of oxidized LDL autoantibodies in rabbits with diet-induced atherosclerosis. Damasceno NRT, Hiro G, Rodrigues FMD, Dias CTS, Okawabata FS, Abdalla DSP, Gidlund M, J Nutr 2000 130 2641 2647 11053500
17. Effect of simvastatin on the generation of autoantibodies against oxidized LDL and progression of atherosclerosis in rabbits. Cavallini DCU, Pauly-Silveira ND, Abdalla DSP, Rossi EA, Latin Am J Pharm 2010 29 1419 1424
18. Etoposide treatment suppresses atherosclerotic plaque development in cholesterol-fed rabbits. Llera-Moya M, Rothblat GH, Glick JM, England JM, Arterioscler Thromb Vasc Biol 1992 12 1363 1370 10.1161/01.ATV.12.11.1363
19. Comparative effects of moxifloxacin and clarithromycin on normal intestinal microflora. Edlund C, Beyer G, Hiemer-Bau M, Ziege S, Lode H, Nord CE, Scand J Infect Dis 2000 32 81 85 10.1080/00365540050164272 10716083 (Pubitemid 30102961)
20. Development and difference of intestinal flora in the neonatal period in breast-fed and bottle-fed infants. Yoshioka H, Iseki K, Fujita K, Pediatrics 1993 72 317 321
21. Selective medium for isolation and enumeration of Bifidobacterium spp. Munoa FJ, Pares R, Appl Environ Microbiol 1988 54 1715 1718 3415235
22. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D, Res Microbiol 2001 152 735 741 10.1016/S0923-2508(01)01254-2 11686387 (Pubitemid 32905506)
23. Lactobacillus paracasei A survives gastrointestinal passage and affects the fecal microbiota of healthy infants. Marzotto M, Maffeis C, Paternoster T, Ferrario R, Rizzotti L, Pellegrino M, Dellaglio F, Torriani S, Res Microbiol 2006 157 857 866 10.1016/j.resmic.2006.06.007 16934438 (Pubitemid 44528975)
24. Microbes in gastrointestinal health and disease. Neish AS, Gastroenterology 2009 136 65 80 10.1053/j.gastro.2008.10.080 19026645
25. Prebiotics and probiotics, modifying and mining the microbiota. Quigley EMM, Pharmacol Res 2010 61 213 218 10.1016/j.phrs.2010.01.004 20080184
26. Effect of fermented soy product on the fecal microbiota of rats fed on a beef-based animal diet. Bedani R, Pauly-Silveira ND, Roselino MN, Valdez GF, Rossi EA, J Sci Food Agric 2010 90 233 238 10.1002/jsfa.3800 20355036
27. The intestine and its microflora are partners for the protection of the host: report on the Danone Symposium ''The Intelligent Intestine'', held in Paris, 14 June 2002. Bourlioux P, Koletzko B, Guarne F, Braesco V, Am J Clin Nutr 2003 78 675 678 14522724
28. Bifidobacteria and their role in human health. Mitsuoka T, J Ind Microbiol 1990 6 263 268 10.1007/BF01575871
29. "Iogurte" de soja como coadjuvante no cancer de mama. Kinouchi FL, PhD thesis São Paulo State University, Clinical Analysis Department 2006
30. Probiotic Enterococcus faecium CRL 183 inhibit chemically induced colon cancer in male Wistar rats. Sivieri K, Spinardi-Barbisan ALT, Barbisan LF, Bedani R, Pauly ND, Carlos IZ, Rossi EA, Eur Food Res Technol 2008 228 231 237 10.1007/s00217-008-0927-6
31. Efeito da ingestão de um produto de soja fermentado com Enterococcus faecium e Lactobacillus helveticus na produção de citocinas, áxido nítrico e peráxido de nitrogênio. Vendramini AP, Master degree dissertation São Paulo State University, Clinical Analysis Department 2002
32. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Steer T, Carpenter H, Tuohy K, Gibson GR, Nutr Res Rev 2000 13 229 254 10.1079/095442200108729089 19087441 (Pubitemid 32125097)
33. Probiotics as modulators of the gut flora. Fooks LJ, Gibson GR, Br J Nutr 2002 88 S1 39 49 10.1079/BJN2002628 12117426
34. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R, Cell 2004 118 229 241 10.1016/j.cell.2004.07.002 15260992 (Pubitemid 38962578)
35. Four-week short chain fructooligosaccharides ingestion leads to increasing fecal bifidobacteria and cholesterol excretion in healthy elderly volunteers. Bouhnik Y, Achour L, Paineau D, Riottot AA, Bournet F, Nutr J 2007
36. Effect of Lactobacillus plantarum 299v on cardiovascular disease risk factor in smokers. Nauruszewicz M, Johansson M-L, Zapolska-Downar D, Bukowska H, Am J Clin Nutr 2002 76 1249 1255 12450890 (Pubitemid 35416559)
37. Effects of Lactobacillus acidophilus 43121 and a mixture of Lactobacillus casei and bifidobacterium longum on the serum cholesterol level and fecal sterol excretion hypercholesterolemia induced pigs. Park YH, Kim JG, Shin YW, Kim HS, Kim YJ, Chun T, Kim SH, Whang KY, Biosci Biotechnol Biochem 2008 72 595 600 10.1271/bbb.70581 18256473 (Pubitemid 351353678)
38. Effects of milk products fermented by bifidobacterium longum on blood lipids in rats and healthy adult male volunteers. Xiao JZ, Kondo S, Takahashi N, Miyaji K, Oshida K, Hiramatsu A, Iwatsuki K, Kokubo S, Hosono A, J Dairy Sci 2003 86 2452 2461 10.3168/jds.S0022-0302(03)73839-9 12906063 (Pubitemid 39001266)
39. Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Wang Y, Xu N, Xi A, Ahmed Z, Zhang B, Bai X, Appl Microbiol Biotechnol 2009 84 341 347 10.1007/s00253-009-2012-x 19444443
40. In vitro effect of Enterococcus faecium and Lactobacillus acidophilus on cholesterol. Rossi EA, Giori GS, Holgado APR, Valdez GF, Microbiologie-aliments- nutrition 1994 12 267 270
41. Homemade traditional cheeses for the isolation of probiotic Enterococcus faecium strains. Saavedra L, Taranto MP, Sesma F, Valdez GF, Int J Food Microbiol 2003 88 241 245 10.1016/S0168-1605(03)00186-7 14596996 (Pubitemid 37329501)
42. Cholesterol assimilation by lactic acid bacteria and bifidobacteria isolated from the human gut. Pereira DIA, Gibson GR, Appl Environ Microbiol 2002 68 4689 4693 10.1128/AEM.68.9.4689-4693.2002 12200334 (Pubitemid 34988161)
43. Progress in the effect of probiotics on cholesterol and its mechanism. Zhao JR, Yang H, Wei Sheng Wu Xue Bao 2005 45 315 319 15989285
44. Cholesterol removal from media by lactococci. Kimoto H, Ohmomo S, Okamoto T, J Dairy Sci 2002 85 3182 3188 10.3168/jds.S0022-0302(02)74406-8 12512591 (Pubitemid 38583311)
45. Consumption of fermented and nonfermented dairy products: effects on cholesterol concentrations and metabolism. St-Onge M-P, Farnworth ER, Jones PJH, Am J Clin Nutr 2000 71 674 681 10702159 (Pubitemid 30118558)
46. Bile salt hydrolase activity in probiotics. Begley M, Hill C, Gahan CGM, Appl Environ Microbiol 2006 72 1729 1738 10.1128/AEM.72.3.1729-1738.2006 16517616
47. Interation between colonic acetate and propionate in humans. Wolever TMS, Spadafora PI, Eshuis H, Am J Clin Nutr 1991 53 681 687 2000822 (Pubitemid 21917642)
48. Dietary Inulin Lowers Plasma Cholesterol and Triacylglycerol and Alters Biliary Bile Acid Profile in Hamsters. Trautwein EA, Rieckhoff D, Erbersdobler HF, J Nutr 1998 128 1937 1943 9808646 (Pubitemid 28509858)
49. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Duncan SH, Louis P, Flint HJ, Appl Environm Microbiol 2004 70 5810 5817 10.1128/AEM.70.10.5810-5817.2004 (Pubitemid 39471821)
50. In vitro fermentation of broiler cecal content: the role of lactobacilli and pH value on the composition of microbiota and end products fermentation. Meimandipou A, Shuhaimi M, Hair-Bejo M, Azhar K, Kabeir BM, Rasti B, Yazid AM, Lett Appl Microbiol 2009 49 415 420 10.1111/j.1472-765X.2009.02674.x 19725887
51. Autoantibodies against oxidized low density lipoprotein: a review of clinical findings and assay methodology. Craig W, J Clin Lab Anal 1995 9 70 74 10.1002/jcla.1860090113 7722776
52. Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D, Arterioscler Thromb Vasc Biol 2000 20 1417 20 10.1161/01.ATV.20.6.1417 10845851 (Pubitemid 30353867)
53. Getting better with bifidobacteria. Leahy SC, Higgins DG, Fitzgerald GF, Van Sinderen D, J Appl Microbiol 2005 98 1303 1315 10.1111/j.1365-2672.2005. 02600.x 15916644 (Pubitemid 40813517)